miR-100-5p modulates postprandial triglyceride response by targeting PCSK9
Amandine VANDUYSE, Alexandre Motte, Carolina Neves, Rita Daclat, Sophie Galier, Olivier Bluteau, Clément Materne, Éric Frisdal, Hervé Durand, Philippe Giral, Joe-Elie Salem, Jean-Marc Lacorte, Cédric Le May, Wilfried Le Goff, Philippe Lesnik, Maryse Guérin
This study identifies miR-100-5p as a regulator of postprandial triglyceride response by targeting PCSK9, suggesting its potential as a biomarker for cardiovascular risk.
Atherosclerosis · Aug 1, 2026Peer-reviewedPhysiology